Breast cancer
Results
Phase 1/2
This trial looked at abiraterone for breast cancer that has spread and is oestrogen receptor positive or androgen receptor positive. It was supported by Cancer Research UK.
Recruitment start: 24 October 2008
Recruitment end: 30 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Johann de Bono
Cancer Research UK (Centre for Drug Development)
Cougar Biotechnology
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/08/044.
Last reviewed: 14 March 2019
CRUK internal database number: 2490
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
